More importantly, to reinforce Blanchette’s findings, another study from a clinical standpoint revealed that the combined expression profile of hepcidin and ferroportin serves as a potent predictor for survival following mastectomy for women with breast cancer (55). This evidence concerns the gene SLC40A1 and breast cancer.